Massachusetts Financial Services’s Acorda Therapeutics ACOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,295
Closed -$257K 859
2020
Q1
$257K Buy
2,295
+363
+19% +$71.5K ﹤0.01% 785
2019
Q4
$473K Sell
1,932
-208
-10% -$52.5K ﹤0.01% 783
2019
Q3
$737K Buy
2,140
+242
+13% +$132K ﹤0.01% 785
2019
Q2
$1.75M Buy
1,898
+1,093
+136% +$1.34M ﹤0.01% 747
2019
Q1
$1.28M Buy
805
+30
+4% +$54K ﹤0.01% 766
2018
Q4
$1.45M Buy
775
+60
+8% +$131K ﹤0.01% 739
2018
Q3
$1.69M Buy
715
+240
+51% +$743K ﹤0.01% 735
2018
Q2
$1.64M Buy
475
+65
+16% +$199K ﹤0.01% 727
2018
Q1
$1.16M Buy
410
+6
+1% +$18K ﹤0.01% 743
2017
Q4
$1.04M Buy
404
+57
+16% +$162K ﹤0.01% 763
2017
Q3
$985K Sell
347
-5
-1% -$13.2K ﹤0.01% 751
2017
Q2
$832K Buy
352
+10
+3% +$19.8K ﹤0.01% 781
2017
Q1
$862K Buy
342
+4
+1% +$11.5K ﹤0.01% 766
2016
Q4
$762K Buy
338
+110
+48% +$262K ﹤0.01% 792
2016
Q3
$571K Buy
228
+53
+30% +$158K ﹤0.01% 806
2016
Q2
$535K Buy
175
+28
+19% +$91.1K ﹤0.01% 782
2016
Q1
$467K Sell
147
-6
-4% -$24.9K ﹤0.01% 786
2015
Q4
$785K Buy
+153
New +$669K ﹤0.01% 748
2013
Q3
Sell
-59
Closed -$234K 852
2013
Q2
$234K Buy
+59
New +$243K ﹤0.01% 798

Other funds holding ACOR

Massachusetts Financial Services's ACOR Position: Q2 2020 in Review

Massachusetts Financial Services sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 2,295 shares — an estimated $257K sold.

Massachusetts Financial Services first reported a position in ACOR in Q2 2013 and held it in 19 quarters. The position peaked at $1.75M in Q2 2019. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Massachusetts Financial Services reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Massachusetts Financial Services sold 2,295 Acorda Therapeutics shares in Q2 2020, an estimated $257K.
  • Massachusetts Financial Services first reported a position in Acorda Therapeutics in Q2 2013 and held it in 19 quarters.
  • Massachusetts Financial Services's Acorda Therapeutics position peaked at $1.75M in Q2 2019.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Massachusetts Financial Services's 13F filing for Q2 2020, filed 11 Aug 2020.